Pediatrics · Infectious Disease · 3 h ago
AAP updates RSV immunization recommendations for infants and children
The American Academy of Pediatrics (AAP) has updated its policy on preventing RSV lower respiratory tract infection in infants and children. It recommends immunization for infants entering their first RSV season and for certain high-risk children entering their second season, with expanded high-risk criteria for the latter group.
- First-season immunization recommended for infants under 8 months.
- Maternal vaccination may provide documented infant protection.
- Second-season eligibility expands for high-risk children aged 8–19 months.
The American Academy of Pediatrics policy statement updates recommendations for RSV immunization to prevent lower respiratory tract infection in infants and children. The statement is based on a review of evidence; the accompanying technical report provides further detail on the evidence and the expanded eligibility criteria.
The AAP recommends immunization for all infants younger than 8 months who are born during or entering their first RSV season, unless they have documented protection through vaccination of the pregnant parent. It also recommends immunization for high-risk infants and children aged 8 through 19 months entering their second RSV season. The statement expands the criteria used to identify children in this second-season group who are at high risk of severe RSV disease.
In practice
The AAP recommends RSV immunization for infants younger than 8 months entering their first RSV season unless they have documented protection from vaccination of the pregnant parent, and for high-risk children aged 8 through 19 months entering a second season. The policy expands the second-season high-risk criteria, but the supplied abstract does not specify them; clinicians need the full statement or accompanying technical report to identify which children newly qualify. These are recommendations, not evidence of a new regulatory approval.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Pediatrics: Recommendations for the Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Policy Statement ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.